BSE filing, NSE: DAULAT. Summary written from the filing by ALFA Finder's alert engine.
Daulat Securities Ltd: key numbers
- Share price
- ₹27.86
- Market cap
- ₹13.93 Cr
- Revenue (annual)
- ₹-1.43 Cr
- Net profit (annual)
- ₹-1.79 Cr
- P/E (TTM)
- -16.8×Sector 19.1×
- Promoter holding
- 56.98%+0.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Daulat Securities Ltd
All →Daulat Securities Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Daulat Securities Management Change
Daulat Securities Limited appointed Mr. Ajit Kochar as Managing Director following the resignation of Mr. Jitendra Kochar. The Board also discussed property monetisation strategies for its immovable assets.
Daulat Securities Other Announcement
A connected person of Daulat Securities acquired 400 equity shares via market purchase.
Daulat Securities Other Announcement
Connected person Aditi Bhutoria acquired 4,000 equity shares of Daulat Securities Ltd for Rs.1,19,360 via market purchase.
- Value
- ₹0.01 Cr
Daulat Securities Board Meeting Date
Daulat Securities intimated that its Board meeting is scheduled for 1 October 2026. Items include noting the MD's resignation and considering immovable property monetisation.
Daulat Securities Other Announcement
Connected person Aditi Bhutoria acquired 844 equity shares of Daulat Securities Ltd for Rs. 0.002 Crore via market purchase.
- Value
- ₹0.00 Cr
Other board meeting date announcements
All →Premier Synthetics Board Meeting Date
Premier Synthetics announced its Board of Directors meeting scheduled for 14 November 2026 to consider unaudited Q2 and H1 results. No financial figures or decisions are reported in this advance notice.
HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.